A striking proportion of the money men spend on skin is spent on conditions the NHS treats. The reason is not that anyone is being deceived. It is that the boundary between a medical condition and a cosmetic concern is not obvious from the outside, and the private market has no incentive to explain it.
1. What is treated
Skin conditions with a clinical basis are treated in the same way as any other medical condition. That includes, non-exhaustively:
- Acne, through the sequence set out in NICE guideline NG198, up to and including specialist referral for isotretinoin. See adult male acne.
- Rosacea, including topical and oral treatment, and referral where indicated. See rosacea in men.
- Eczema, dermatitis and psoriasis, including occupational contact dermatitis and patch testing where allergic contact dermatitis is suspected.
- Seborrhoeic dermatitis, though many treatments are available directly from a pharmacy.
- Fungal and bacterial skin infections.
- Suspected skin cancer, with an urgent referral pathway under NICE guideline NG12, and treatment of actinic keratoses.
- Hyperhidrosis, where it is severe and simpler measures have failed, though thresholds vary locally. See hyperhidrosis in men.
- Scarring alopecias and other medical hair loss, as distinct from androgenetic alopecia.
2. What is not routinely funded
- Cosmetic injectables for lines and volume.
- Laser and light treatment where the purpose is appearance rather than treating a condition.
- Treatment for male pattern hair loss, including finasteride and minoxidil for that indication.
- Cosmetic surgery, and cosmetic hair transplantation.
- Removal of benign lesions such as skin tags, most moles and seborrhoeic keratoses where they are not causing a clinical problem and are not suspicious.
- Tattoo removal, in most circumstances.
- Chemical peels and other resurfacing performed for appearance.
Commissioning policies for procedures of limited clinical value vary between local areas, and some treatments are available in defined exceptional circumstances through an individual funding request. That route exists, is not quick, and requires a clinical case.
3. The genuine grey areas
Benign lesion removal. A skin tag catching on a collar and repeatedly bleeding is a different proposition from the same lesion causing no problem. Where a lesion is symptomatic or where malignancy cannot be excluded, it falls on the medical side.
Scarring. Acne scarring is generally treated as cosmetic once active disease has been controlled, but treatment of active acne to prevent further scarring is not.
Psychological impact. This is explicitly recognised in some guidance. In acne, for example, psychological impact is a stated consideration in referral. It is a legitimate part of a consultation rather than something to leave out.
Hyperhidrosis. The clearest example of a condition where the boundary is functional rather than anatomical, and where local thresholds genuinely differ.
4. How access actually works
| Route | Suitable for | Notes |
|---|---|---|
| Community pharmacy | Common conditions, treatment advice, many over the counter options | No appointment; in England the NHS has expanded what pharmacy can manage directly |
| GP | Diagnosis, prescription treatment, referral | The entry point for specialist care |
| Urgent suspected cancer referral | Suspicious lesions | Defined thresholds under NICE guideline NG12 |
| Routine dermatology referral | Conditions not responding to primary care treatment | Waiting times vary considerably by area |
| Occupational health | Work related skin disease | Available in some workplaces; health surveillance is required in some trades |
| Individual funding request | Exceptional cases for otherwise unfunded treatment | Slow, requires a clinical case |
5. When paying privately is reasonable
There are legitimate reasons to pay. Waiting times for routine dermatology can be long. A treatment may not be funded locally. A man may want a cosmetic outcome that is not a medical need, which is an entirely reasonable thing to want and to pay for.
The unreasonable version is paying privately for a condition that would have been treated free, because nobody explained that it was a condition. Acne, rosacea, seborrhoeic dermatitis and hyperhidrosis are the four where this happens most, and all four are routinely presented to men as cosmetic problems with cosmetic solutions.
6. A note on mixing the two
Patients are entitled to combine NHS and private care, subject to rules on not mixing the two within a single episode of care. In practice the important points are that a private consultation does not accelerate NHS treatment, that a private prescription is paid for at the pharmacy at the full cost of the medicine, and that a diagnosis made privately still generally requires a GP to arrange NHS follow up.
7. Before paying for anything
Three questions first
- Is this a named condition? If it has a diagnosis, there is probably an NHS pathway, and a pharmacist can often tell you within a few minutes.
- Has it been assessed by anyone qualified to diagnose it? Paying for a treatment before a diagnosis is the most common way men waste money on skin.
- Is the private provider treating the condition or the appearance? Both are legitimate, and they are not the same purchase.
8. Prescription charges and what they cover
A practical point that changes the arithmetic. In England there is a flat prescription charge per item, with a prepayment certificate available that caps the cost for anyone needing several items over a year. Prescriptions are free in Scotland, Wales and Northern Ireland, and free in England for people in defined exemption categories.
This matters for skin because several conditions covered here involve multiple items: an emollient, a topical treatment and sometimes an oral course. For a man with hand dermatitis needing emollient in quantity, or acne needing a topical combination alongside an oral antibiotic, a prepayment certificate is frequently cheaper than paying per item.
It also matters because emollients and some antifungal preparations can be bought without prescription, sometimes for less than the charge and sometimes for considerably more. A pharmacist will say which applies, and asking is worth more than assuming either way. That conversation is free and does not require an appointment, which makes it the most under-used resource in this entire subject.